Zejula is indicated:• as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high gradeserous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial)to platinum based chemotherapy.• as monotherapy for the maintenance treatment of adult patients with advanced epithelial (FIGO Stages IIIand IV) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete orpartial) following completion of first-line platinum-based chemotherapy.